FDA OKs Takeda, Protagonist drug for rare blood cancer
STAT+: GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care
Nature Biotechnology, Published online: 31 August 2026; doi:10.1038/s41587-026-03213-1Symbiotic relationships of microorganisms are predicted and cataloged with a machine learning tool.
Juul gets OK to sell updated vaping device with age-gating technology
Opinion: The unintended consequences of the Lindsay Clancy case
AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease
STAT+: FDA approves Roivant therapy for rare autoimmune disease
STAT+: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
Spyre tumbles as immune drug misses mark in rheumatoid arthritis
Scan to Read